Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05726175
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-02-13
First Post:
2023-01-30
Brief Title:
Disitamab VedotinRC48 Combined With PenpulimabAK105 for Neoadjuvant Treatment of HER2-low Breast Cancer
Sponsor:
Organization:
West China Hospital